New Drugs Developed to Fight Covid-19

Two new drugs were developed by the Australian scientists. The first drug would be given pre-exposure to the virus, which helps boost the efficacy of vaccines and the second drug helps stop the spread of the covid-19 virus in already infected cells.

Two new drugs developed prevents Covid-19 infection and treats people who have been exposed to the virus, reveal scientists from QIMR Berghofer Medical Research Institute in Australia's Queensland.//

The two early intervention drugs target how human cells respond to the SARS-CoV-2 virus, instead of the virus itself, according to the findings published in the journal Nature Cell Discovery.

Mechanism of Severe Post-COVID-19 Disease in Kids Revealed
Research team of MassGeneral Hospital for Children (MGHfC), Brigham and Women's Hospital and other institutions have identified the mechanism of how an extremely rare but serious post-COVID-19 complication develops in children and adolescents.

‘Among the 2 drugs developed by the Australian scientists, the first drug would be given pre-exposure to the virus, which helps boost the efficacy of vaccines and the second drug helps stop the spread of the covid-19 virus in already infected cells.’

The first peptide-based drug would be given pre-exposure to the virus and help boost the efficacy of vaccines, while the second drug would stop the spread of the virus in already infected cells.

Laboratory tests show the first peptide-based drug reduces infection by cloaking the ACE2 receptor protein on human cells. The SARS-CoV-2 spike protein uses the ACE2 receptor to bind to and invade cells. The virus then latches onto the cloaking peptides, which they mistake for human cells -- preventing infection.

The lab tests have also shown that if the virus finds its way into cells, the second peptide-drug can block how the virus hijacks the host cell and replicates. It also boosts the immune system's ability to recognize the virus.

COVID-19 Pandemic Global Radar
COVID-19 pandemic radar system will be developed by WHO and Britain to trace new coronavirus variants quickly for rapid development of vaccines, treatments and tests.

Professor Sudha Rao, head of QIMR Berghofer's Gene Regulation and Translational Medicine Group, said they were able to develop the drugs after discovering that some people have a chemical tag which acts like a padlock on the ACE2 receptor.

"The tag can either keep the receptor locked or open -- controlling infection. This means people who have the 'padlock-like' tag on their ACE2 receptors will be less susceptible to SARS-CoV-2 and those without the tag are more vulnerable to infection," Rao said.

COVID-19 Variant Struggle Against Vaccines
Coronavirus variant B.1.617.2 dominating in India causing severe symptomatic infection surrenders with two doses of AstraZeneca’s Covishield vaccine, reveals the UK study.

"Our drugs stop the tag from being removed and also protect the untagged ACE2 receptors from being infected."

The researchers also discovered that if the virus invaded the cells, it would unlock the tag from the inside -- allowing more efficient virus replication.

Steroids Contraindicated for Mild COVID-19 Patients
Amid rise of mucormycosis (black fungus) infection, diabetic patients are advised to frequently monitor and control their blood sugar levels.

The drugs are also stable and can be stored at room temperature, which would make them easy to distribute.

The research was conducted on Covid-19 patient blood and human cells and the drugs are now being tested in hamsters at France's pre-clinical and clinical research facility, IDMIT, with promising early results showing they are not toxic and have few side effects.

Source-IANS